10/9
08:00 am
dxr
DAXOR'S INNOVATIVE BVA-100™ BLOOD VOLUME DIAGNOSTIC FEATURED AT MEDAXIOM CV TRANSFORUM FALL '24
Low
Report
DAXOR'S INNOVATIVE BVA-100™ BLOOD VOLUME DIAGNOSTIC FEATURED AT MEDAXIOM CV TRANSFORUM FALL '24
10/8
08:00 am
dxr
Daxor Corporation to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit
Low
Report
Daxor Corporation to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit
9/27
05:05 pm
dxr
Daxor Corporation Streamlines Regulatory Strategy for Groundbreaking Diagnostic Device [Yahoo! Finance]
Low
Report
Daxor Corporation Streamlines Regulatory Strategy for Groundbreaking Diagnostic Device [Yahoo! Finance]
9/27
05:00 pm
dxr
Daxor Corporation Streamlines Regulatory Strategy for Groundbreaking Diagnostic Device
Low
Report
Daxor Corporation Streamlines Regulatory Strategy for Groundbreaking Diagnostic Device
9/19
08:00 am
dxr
Daxor Corporation to Exhibit at the Heart Failure Society of America Annual Scientific Meeting 2024
Low
Report
Daxor Corporation to Exhibit at the Heart Failure Society of America Annual Scientific Meeting 2024
9/12
08:00 am
dxr
Newly Published Review Highlights the Pivotal Role of Daxor’s Blood Volume Analysis Technology in Advancing Cardiorenal Syndrome Management
Low
Report
Newly Published Review Highlights the Pivotal Role of Daxor’s Blood Volume Analysis Technology in Advancing Cardiorenal Syndrome Management
9/9
08:08 am
dxr
Daxor Co. (NASDAQ: DXR) had its price target raised by analysts at Ascendiant Capital Markets from $24.50 to $24.75. They now have a "buy" rating on the stock.
Medium
Report
Daxor Co. (NASDAQ: DXR) had its price target raised by analysts at Ascendiant Capital Markets from $24.50 to $24.75. They now have a "buy" rating on the stock.
9/5
08:00 am
dxr
Daxor Corporation Receives $300K Matching Fund Award From Launch Tennessee
Medium
Report
Daxor Corporation Receives $300K Matching Fund Award From Launch Tennessee
9/4
08:30 am
dxr
Leading Central Florida Hospital Implements Daxor’s BVA-100™ Blood Volume Diagnostic for Heart Failure Patient Care
Medium
Report
Leading Central Florida Hospital Implements Daxor’s BVA-100™ Blood Volume Diagnostic for Heart Failure Patient Care
9/3
04:19 pm
dxr
Daxor Corporation CEO and President Michael Feldschuh Delivers Corporate Update in Shareholder Letter [Yahoo! Finance]
Medium
Report
Daxor Corporation CEO and President Michael Feldschuh Delivers Corporate Update in Shareholder Letter [Yahoo! Finance]
9/3
04:05 pm
dxr
Daxor Corporation CEO and President Michael Feldschuh Delivers Corporate Update in Shareholder Letter
Medium
Report
Daxor Corporation CEO and President Michael Feldschuh Delivers Corporate Update in Shareholder Letter
9/3
12:15 pm
dxr
Daxor Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Medium
Report
Daxor Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference
8/29
08:00 am
dxr
Daxor Corporation Announces Launch of BVA Program at Mid-South Largest Integrated Network
High
Report
Daxor Corporation Announces Launch of BVA Program at Mid-South Largest Integrated Network